A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis | MicrobiomeTrials
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2021-03-23Est. Completion: 2029-01-01
Enrollment target: 153 participants
Locations
Instituto de Neumonologia Y Dermatologia, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Psoriahue, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
CONEXA Investigacion Clinica S.A., Buenos Aires, Argentina
Centro de Investigaciones Metabólicas (CINME), Buenos Aires, Argentina
Hospital Italiano de Buenos Aires, CABA, Argentina
Consultora Integral de Salud, Córdoba, Argentina
Local Institution - 0020, Darlinghurst, New South Wales, Australia
Local Institution - 0002, Westmead, New South Wales, Australia
Queensland Children's Hospital, Brisbane, Queensland, Australia
Local Institution - 0003, Woolloongabba, Queensland, Australia
Monash Health, Clayton, Victoria, Australia
Local Institution - 0001, Melbourne, Victoria, Australia
Centro de Pesquisas da Clínica IBIS, Salvador, Estado de Bahia, Brazil
Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) - HCFMRP, Ribeirão Preto, São Paulo, Brazil
Other microbiome trials you might be interested in